Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications
Antibiotics · 16.01.2023 · 12 (1) · 184
DOI: 10.3390/antibiotics12010184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 16.01.2023. Verfasst von Esther Imperlini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department for Innovation in Biological, Agrofood and Forest Systems, University of Tuscia, 01100 Viterbo, Italy. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union—NextGeneration EU through Italian NRRP.
Abstract (Originalsprache)
The introduction of antibiotics has revolutionized the treatment and prevention of microbial infections. However, the global spread of pathogens resistant to available antibiotics is a major concern. Recently, the WHO has updated the priority list of multidrug-resistant (MDR) species for which the discovery of new therapeutics is urgently needed. In this scenario, antimicrobial peptides (AMPs) are a new potential alternative to conventional antibiotics, as they show a low risk of developing antimicrobial resistance, thus preventing MDR bacterial infections. However, there are limitations and challenges related to the clinical impact of AMPs, as well as great scientific efforts to find solutions aimed at improving their biological activity, in vivo stability, and bioavailability by reducing the eventual toxicity. To overcome some of these issues, different types of nanoparticles (NPs) have been developed for AMP delivery over the last decades. In this review, we provide an update on recent nanosystems applied to AMPs, with special attention on their potential pharmaceutical applications for the treatment of bacterial infections. Among lipid nanomaterials, solid lipid NPs and lipid nanocapsules have been employed to enhance AMP solubility and protect peptides from proteolytic degradation. In addition, polymeric NPs, particularly nanogels, are able to help in reducing AMP toxicity and also increasing AMP loading. To boost AMP activity instead, mesoporous silica or gold NPs can be selected due to their easy surface functionalization. They have been also used as nanocarriers for different AMP combinations, thus synergistically potentiating their action against pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Innovation in Biological, Agrofood and Forest Systems, University of Tuscia, 01100 Viterbo, Italy.
ORCID-Profile: Esther Imperlini, Francesco Buonocore
Förderung
- European Union—NextGeneration EU through Italian NRRP
Zitieren
APA
Imperlini, E., Massaro, F., & Buonocore, F. (2023). Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications. Antibiotics, 12(1), 184. https://doi.org/10.3390/antibiotics12010184
Vancouver
Imperlini E, Massaro F, Buonocore F. Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications. Antibiotics. 2023;12(1):184. doi:10.3390/antibiotics12010184
BibTeX
@article{Imperlini2023,
author = {Imperlini, Esther and Massaro, Federica and Buonocore, Francesco},
title = {Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {1},
pages = {184},
doi = {10.3390/antibiotics12010184}
}
EUVIMED